DrugsNews.net

Drugs Xagena

Search results for "Siponimod"

Multiple sclerosis: FDA has approved Mayzent, an oral drug to treat clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease

The FDA ( U.S. Food and Drug Administration ) has approved Mayzent ( Siponimod ) tablets to treat adults with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing- ...

Mayzent for adult patients with secondary progressive multiple sclerosis with active disease, approved in European Union

The European Commission ( EC ) has approved Mayzent ( Siponimod ) for the treatment of adult patients with secondary progressive multiple sclerosis ( SPMS ) with active disease evidenced by relapses o ...

Keywords

MedTV

Antibiotici nel trattamento della Broncopneumopatia Cronica Ostruttiva riacutizzata

Polmoniti comunitarie - Percorso Diagnostico-Terapeutico

Terapia Antibiotica per le Infezioni Urinarie Non-Complicate Cistite

Sinusiti Mascellari Odontogene

Terapia Antibiotica Empirica

Linee Guida per il Trattamento delle Sinusiti Batteriche Acute negli Adulti e nei Bambini

Ruolo della Betaistina nel trattamento di pazienti con sintomi vertiginose

Cosa fare di fronte al paziente che riferisce vertigini?

Resistenza batterica agli antibiotici

Basi per il corretto impiego degli antibiotici in Medicina Generale